Internal Medicine, Infectious Disease · Oklahoma City, OK
NPI
1609845437
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
711 Stanton L Young Blvd, Ppb Suite 430
Oklahoma City, OK, 73104
Phone (405) 271-6434
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
249 services
Medicare patients, 2024
111
Average age 68
Drug cost, 2024
$2.6M
2,123 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle R Salvaggio was code 99232 (hospital e&m - subsequent), 101 times for 47 patients. In total Michelle R Salvaggio billed 249 services in 15 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 101 | 47 | $57.35 | $5,792 |
| 99214 Office E&M - Established | Facility | 39 | 24 | $60.17 | $2,346 |
| 99233 Hospital E&M - Subsequent | Facility | 32 | 21 | $86.41 | $2,765 |
| 99223 Hospital E&M - Initial | Facility | 31 | 31 | $128.70 | $3,990 |
| 99213 Office E&M - Established | Facility | 12 | 11 | $36.72 | $441 |
| 99215 Office E&M - Established | Facility | 12 | 12 | $106.53 | $1,278 |
By year: 2022 $21K for 292 services; 2023 $25K for 336 services; 2024 $18K for 249 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle R Salvaggio prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 177 prescriptions and refills. In total Michelle R Salvaggio wrote 2,123 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 177 | 177 | 28 | $699K |
| Descovy Emtricitabine/Tenofov Alafenam | 139 | 139 | 18 | $306K |
| Atorvastatin Calcium Generic | 137 | 186 | 22 | $491 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 135 | 135 | 14 | $500K |
| Tivicay Dolutegravir Sodium | 80 | 80 | Under 11 | $205K |
| Hydrochlorothiazide Generic | 77 | 89 | 13 | $148 |
| Omeprazole Generic | 70 | 90 | 11 | $464 |
| Rosuvastatin Calcium Generic | 65 | 89 | 14 | $263 |
| Metformin Hcl Generic | 47 | 51 | Under 11 | $63.92 |
| Pifeltro Doravirine | 42 | 42 | Under 11 | $76K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 42 | 42 | Under 11 | $163K |
| Prezcobix Darunavir/Cobicistat | 41 | 41 | Under 11 | $102K |
| Amlodipine Besylate Generic | 40 | 52 | Under 11 | $90.19 |
| Juluca Dolutegravir/Rilpivirine | 38 | 38 | Under 11 | $130K |
| Evotaz Atazanavir Sulfate/Cobicistat | 35 | 35 | Under 11 | $53K |
Brand drugs: 897 claims; generic drugs: 1,226 claims; opioid claims: 62.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michelle R Salvaggio were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.